Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 22.22
(0.63%)
CNY 22.22
(0.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 315.05 Million | 341.28 Million | 296.69 Million | 256.35 Million | 207.91 Million | 171.51 Million |
| Net Income | 254.48 Million | 277.51 Million | 200.31 Million | 151.71 Million | 123.89 Million | 107.65 Million |
| Depreciation & Amortization | 76.22 Million | 64.37 Million | 53.89 Million | 43.33 Million | 41.03 Million | 38.8 Million |
| Deferred income taxes | 733.46 Thousand | -210.96 Thousand | 667.46 Thousand | -17.1 Thousand | -720.52 Thousand | 311.56 Thousand |
| Stock-based compensation | - | - | 4.39 Million | 18.74 Million | 42.73 Million | 35.29 Million |
| Change in working capital | -51 Million | -26.4 Million | 9.48 Million | 22.74 Million | 2.71 Million | -9.27 Million |
| Other non-cash items | 40.57 Million | 25.8 Million | 27.94 Million | 19.83 Million | -1.74 Million | 34.32 Million |
| Investing Cash Flow | -1.29 Billion | -85.39 Million | -233.72 Million | 89.65 Million | -53.89 Million | -249.03 Million |
| Investments in PPE | -414.54 Million | -182.6 Million | -161.62 Million | -64.97 Million | -91.48 Million | -232.84 Million |
| Acquisitions | -5101.71 | -816.61 Thousand | 953.09 Thousand | 64.97 Million | 91.51 Million | - |
| Investment purchases | -1.45 Billion | -158.22 Million | -458.2 Million | -465.52 Million | -711.5 Million | -603.78 Million |
| Sales/Maturities of investments | 565.64 Million | 256.24 Million | 386.05 Million | 620.14 Million | 749.05 Million | 587.59 Million |
| Other Investing Activities | -884.23 Million | 0.04 | -899.99 Thousand | -64.97 Million | -91.48 Million | 147.11 |
| Financing Cash Flow | 290.08 Million | 335.83 Million | -54.24 Million | 117.61 Million | -56.42 Million | 96.35 Million |
| Debt repayment | -135.78 Million | -661.94 Million | -18.84 Thousand | -10 Million | -40 Million | -76.09 Million |
| Dividends payments | -87.22 Million | -60.31 Million | -45.88 Million | -49.37 Million | -33.06 Million | -28.97 Million |
| Common Stock Repurchased | - | - | -2.09 Million | -173.13 Million | -2.95 Million | - |
| Common Stock Issuance | - | - | 2.09 Million | 173.13 Million | 2.95 Million | - |
| Other Financing Activities | 247.07 Million | 1.05 Billion | -6.71 Million | 177.2 Million | 17.03 Million | 201.42 Million |
| Accounts receivables | -18.96 Million | -16.19 Million | -27.89 Million | -18.37 Million | -9.06 Million | -23.85 Million |
| Accounts payables | -22.68 Million | 38.68 Million | 36.39 Million | 30.42 Million | 3.97 Million | 20.19 Million |
| Inventory | -10.07 Million | -48.69 Million | 315.67 Thousand | 10.71 Million | 8.52 Million | -5.91 Million |
| Other working capital | -21.95 Million | -210.96 Thousand | 667.47 Thousand | -17.1 Thousand | -720.52 Thousand | -3.35 Million |
| Cash at beginning of period | 1.26 Billion | 677.98 Million | 669.24 Million | 205.62 Million | 108.02 Million | 89.19 Million |
| Cash at end of period | 576.06 Million | 1.26 Billion | 677.98 Million | 669.24 Million | 205.62 Million | 108.02 Million |
| Capital Expenditure | -414.54 Million | -182.6 Million | -161.62 Million | -64.97 Million | -91.48 Million | -232.84 Million |
| Effect of forex changes on cash | - | 0.97 | 0.34 | 1.00 | -0.09 | 0.34 |
| Net cash flow / Change in cash | -693.64 Million | 591.72 Million | 8.73 Million | 463.62 Million | 97.59 Million | 18.83 Million |
| Free Cash Flow | -99.48 Million | 158.68 Million | 135.07 Million | 191.37 Million | 116.43 Million | -61.32 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 17.79 Million | 23.74 Million | 77.13 Million | 115.11 Million | 254.48 Million | 49.12 Million |
| Depreciation & Amortization | - | 25.48 Million | 25.48 Million | 25.08 Million | 76.22 Million | -39.72 Million |
| Deferred income taxes | - | - | - | - | 733.46 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -49.07 Million | - | -29.04 Million | -51 Million | 20.04 Million |
| Other non-cash items | -3.45 Million | 83.75 Million | -27.88 Million | 5.09 Million | 40.57 Million | 4.19 Million |
| Investing Cash Flow | -65.05 Million | 149.85 Million | 132.59 Million | -1.02 Billion | -1.29 Billion | -249.78 Million |
| Investments in PPE | -170.76 Million | -116.14 Million | -176.61 Million | -105.3 Million | -414.54 Million | -249.78 Million |
| Acquisitions | 16.59 Thousand | - | 224.2 Million | -5101.00 | -5101.71 | - |
| Investment purchases | -115 Million | -494 Million | -25 Million | -1.41 Billion | -1.45 Billion | -1000.00 |
| Sales/Maturities of investments | 220.7 Million | 760 Million | 110 Million | 499.95 Million | 565.64 Million | - |
| Other Investing Activities | 16.59 Thousand | 268.59 Million | 309.2 Million | -919.94 Million | -884.23 Million | -1000.00 |
| Financing Cash Flow | -47.48 Million | -189.42 Million | -7.81 Million | 387.09 Million | 290.08 Million | -36.25 Million |
| Debt repayment | -42.88 Million | -134.98 Million | -27.17 Million | -70.54 Million | -135.78 Million | -190 Million |
| Dividends payments | -1.82 Million | -79.8 Million | - | -87.22 Million | -87.22 Million | -35.06 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.77 Million | -44.81 Million | -34.99 Million | 322.1 Million | 247.07 Million | 188.81 Million |
| Accounts receivables | - | 123.11 Thousand | - | -18.96 Million | -18.96 Million | -17.48 Million |
| Accounts payables | - | - | - | - | -22.68 Million | - |
| Inventory | - | -49.19 Million | - | -10.07 Million | -10.07 Million | 37.53 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 792.52 Million | 1.62 Billion | 576.06 Million | 1.09 Billion | 1.26 Billion | 1.34 Billion |
| Cash at end of period | 694.32 Million | 1.09 Billion | 750.08 Million | 576.06 Million | 576.06 Million | 1.09 Billion |
| Capital Expenditure | -170.76 Million | -116.14 Million | -176.61 Million | -105.3 Million | -414.54 Million | -249.78 Million |
| Effect of forex changes on cash | - | - | - | - | - | 0.79 |
| Net cash flow / Change in cash | -98.19 Million | -526.27 Million | 174.01 Million | -517.93 Million | -693.64 Million | -252.39 Million |
| Free Cash Flow | -156.42 Million | -34.13 Million | -127.37 Million | 14.91 Million | -99.48 Million | -216.14 Million |
3900
PNP
UPIN
CAPRO
AXLX
BAHI3